Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients (TBIDU)

This study has been completed.
Sponsor:
Collaborators:
LLC Corrigo
Ida-Viru Central Hospital, Department of Tuberculosis
Information provided by:
National Institute for Health Development, Estonia
ClinicalTrials.gov Identifier:
NCT01290081
First received: February 3, 2011
Last updated: NA
Last verified: January 2008
History: No changes posted
  Purpose

The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.


Condition Intervention
Tuberculosis
Other: Case management approach in referral to health care services

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Prevalence of Latent Tuberculosis and Enhanced Tuberculosis Case Detection Among Injecting Drug Users Receiving Methadone Substitution Treatment

Resource links provided by NLM:


Further study details as provided by National Institute for Health Development, Estonia:

Enrollment: 112
Study Start Date: October 2007
Study Completion Date: January 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Active referral
Case management intervention group - study personnel scheduled the TB doctor appointment for the participant, reminded to keep it, and transportation to the clinic was organized when needed.
Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program
No Intervention: Passive referral
Participants were instructed to schedule an appointment with TB services themselves.
Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Participation in substitution treatment program,
  • Age 18 years or more,
  • Able to read and write in Estonian or Russian,
  • Able to provide informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01290081

Locations
Estonia
LLC Corrigo
Jõhvi, Ida-Virumaa, Estonia, 41532
Sponsors and Collaborators
National Institute for Health Development, Estonia
LLC Corrigo
Ida-Viru Central Hospital, Department of Tuberculosis
  More Information

No publications provided

Responsible Party: Kristi Rüütel, National Institute for Health Development
ClinicalTrials.gov Identifier: NCT01290081     History of Changes
Other Study ID Numbers: TBIDU-1230
Study First Received: February 3, 2011
Last Updated: February 3, 2011
Health Authority: Estonia: National Institute for Health Development

Keywords provided by National Institute for Health Development, Estonia:
Tuberculosis
Injecting drug users
Case management

Additional relevant MeSH terms:
Tuberculosis
Latent Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on April 21, 2014